Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Treakisym in combination with rituximab approved in Japan as treatment of R/R DLBCL

March 25, 2021

Vidaza receives extended approval in Japan for acute myeloid leukemia

March 25, 2021

Vitrakvi approved in Japan for NTRK fusion-positive advanced or recurrent solid tumors

March 25, 2021

Kochi University discovers new KHSRP inhibitors

March 25, 2021

Chinese investigators patent TRK inhibitors

March 25, 2021

HiberCell identifies PERK inhibitors

March 25, 2021

Ferro Therapeutics synthesizes new PHGPx inhibitors

March 25, 2021

SF-1 antagonist OR-449 for treating ACC

March 25, 2021

Basilea reports further interim data from phase II study of derazantinib in bile duct cancer

March 24, 2021

Japanese approval of Lenvima for unresectable thymic carcinoma

March 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...